Genomic analysis reveals a novel mechanism that drives aggressive bone cancer and a potential biomarker

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation.

Leave A Comment

Your email address will not be published. Required fields are marked *